Patent · US Expired

1,2,4-Benzotriazine oxides as radiosensitizers and selective cytotoxic agents

US6828321B2 · kind B2 · utility

5Cited by
19References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2001
Grant dateDec 7, 2004
Priority date
Expiry dateDec 17, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D253/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of using 1,2,4-benzotriazine oxides, some of which are novel compounds, as radiosensitizers and selective cytotoxic agents is disclosed. These compounds are shown to specifically radiosensitize hypoxic tumor cells. Some are additionally disclosed to be useful as specific cytotoxic agents for these cells. They also show an unexpected ability to radiosensitize aerobic cells following or preceding a hypoxic incubation of the cells with the drug. This provides a basis for selective radiosensitization of tumors compared to normal cells. A novel method for preparing the 1,2,4-benzotriazine oxides is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.